BridgeMD
Prevention study for ICU Delirium
Official title Virtual Reality for ICU Delirium Prevention
ClinicalTrials.gov ID: NCT07357389
What this study is testing
- What it's testing
- The purpose of this study is to evaluate whether daily exposure to immersive virtual reality (VR) can reduce the incidence of delirium in high-risk, non-intubated ICU patients. Participants will be randomized to either standard ICU care or standard care plus once-daily 15-minute VR sessions consisting of calming natural scenes, guided meditation, and music.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Individuals who are currently admitted to the SICU at Cedars-Sinai Medical Center
- Expected ICU stay \>48 hours
- Richmond Agitation Sedation Scale (RASS) score between -1 to +2.
- CAM-ICU negative
- 1≤ risk factor for delirium (Age ≥ 65 years old, history of cognitive impairment, sepsis, Sequential Organ Failure Assessment (SOFA) score \>5...
You likely can't join if
- Unwilling and/or unable to participate
- Intubation of tracheostomy
- Self-reported history of severe motion sickness
- Inability to follow commands (e.g. severe aphasia, deafness, GCS\<13)
- The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted device (HMD
- Those that require corrective lenses -2.5 or stronger that cannot be corrected with contact lenses
See the full eligibility criteria
- Individuals who are currently admitted to the SICU at Cedars-Sinai Medical Center
- Expected ICU stay \>48 hours
- Richmond Agitation Sedation Scale (RASS) score between -1 to +2.
- CAM-ICU negative
- 1≤ risk factor for delirium (Age ≥ 65 years old, history of cognitive impairment, sepsis, Sequential Organ Failure Assessment (SOFA) score \>5, history of alcohol or benzodiazepine abuse, recent major surgery)
- Unwilling and/or unable to participate
- Intubation of tracheostomy
- Self-reported history of severe motion sickness
- Inability to follow commands (e.g. severe aphasia, deafness, GCS\<13)
- The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted device (HMD
- Those that require corrective lenses -2.5 or stronger that cannot be corrected with contact lenses
- Having had a seizure in the past year
- Unable to understand the instructions or to consent to participation in the study.
- Those who are pregnant
- Hemodynamic instability (MAP\<65 despite support)
- End-of-life care
- Severe agitation or delirium (i.e. CAM-ICU + screen)
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.